IRIS ENERGY LTD (IREN)

AU0000185993 - Common Stock

5.17  -0.08 (-1.52%)

Premarket: 5.16 -0.01 (-0.19%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to IREN. IREN was compared to 276 industry peers in the Software industry. IREN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. IREN is not overvalued while it is showing excellent growth. This is an interesting combination.



0

1. Profitability

1.1 Basic Checks

IREN had negative earnings in the past year.
IREN had a positive operating cash flow in the past year.

1.2 Ratios

IREN has a worse Return On Assets (-41.20%) than 78.47% of its industry peers.
With a Return On Equity value of -45.01%, IREN is not doing good in the industry: 63.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -41.2%
ROE -45.01%
ROIC N/A
ROA(3y)-56.74%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IREN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

IREN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IREN has more shares outstanding
Compared to 1 year ago, IREN has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 7.50 indicates that IREN is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 7.50, IREN is doing good in the industry, outperforming 79.93% of the companies in the same industry.
A Debt/Equity ratio of 0.00 indicates that IREN is not too dependend on debt financing.
IREN has a better Debt to Equity ratio (0.00) than 67.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 7.5
ROIC/WACCN/A
WACC9.47%

2.3 Liquidity

IREN has a Current Ratio of 3.38. This indicates that IREN is financially healthy and has no problem in meeting its short term obligations.
IREN has a Current ratio of 3.38. This is in the better half of the industry: IREN outperforms 77.74% of its industry peers.
A Quick Ratio of 3.38 indicates that IREN has no problem at all paying its short term obligations.
IREN has a Quick ratio of 3.38. This is in the better half of the industry: IREN outperforms 77.74% of its industry peers.
Industry RankSector Rank
Current Ratio 3.38
Quick Ratio 3.38

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 69.37% over the past year.
Looking at the last year, IREN shows a very strong growth in Revenue. The Revenue has grown by 27.90%.
IREN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 226.47% yearly.
EPS 1Y (TTM)69.37%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q90.41%
Revenue 1Y (TTM)27.9%
Revenue growth 3Y226.47%
Revenue growth 5YN/A
Revenue growth Q2Q209.4%

3.2 Future

IREN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 31.44% yearly.
IREN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 78.47% yearly.
EPS Next Y97.73%
EPS Next 2Y49.37%
EPS Next 3Y31.44%
EPS Next 5YN/A
Revenue Next Year130.43%
Revenue Next 2Y114.15%
Revenue Next 3Y78.47%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IREN. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 7.24, which indicates a rather cheap valuation of IREN.
IREN's Price/Forward Earnings ratio is rather cheap when compared to the industry. IREN is cheaper than 96.72% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IREN to the average of the S&P500 Index (21.63), we can say IREN is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 7.24

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

IREN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IREN's earnings are expected to grow with 31.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.37%
EPS Next 3Y31.44%

0

5. Dividend

5.1 Amount

IREN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IRIS ENERGY LTD

NASDAQ:IREN (4/25/2024, 7:00:03 PM)

Premarket: 5.16 -0.01 (-0.19%)

5.17

-0.08 (-1.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap568.18M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.24
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.2%
ROE -45.01%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.38
Quick Ratio 3.38
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)69.37%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y97.73%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.9%
Revenue growth 3Y226.47%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y